JT

Jan Thirkettle

Chief Executive Officer

Harness Therapeutics

Cambridge, England


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Harness Therapeutics
Industry
research
Employees
32.0
Seniority
C suite
Annual Revenue
1000000.0
Total Funding
36417572.0
Latest Funding
Venture (Round not Specified)

Technologies

Outlook Microsoft Office 365 Mobile Friendly Google Maps (Non Paid Users) Google Maps Google Tag Manager reCAPTCHA

Keywords

neurodegeneration rna therapeutics physiological upregulation posttranscriptional upregulation mrna aso sineup biotechnology research huntington's disease als alzheimer's disease neurodegenerative disorders protein translation rna biology disease modification therapeutic targets gene therapy mrna-targeted oligonucleotides fan1 tdp-43 neuronal cell models clinical trials biotechnology bioinformatics analytical methods rna translation platform controlled upregulation safety profile biopharmaceuticals cag repeat expansion genetic mutations spinal muscular atrophy therapeutic approaches high-throughput screening customized rna constructs neurogenesis nuclear import receptor molecular biology genetic engineering patient datasets translational research clinical development neuropharmacology longitudinal studies biostatistics small molecules therapeutic antibodies ipsc models clinical validation cns diseases disease progression rna-targeted therapies therapeutic window expressive gene delivery investor relations clinical safety pipeline development health care health wellness & fitness hospital & health care information technology & services

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans